U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789028) titled 'A Study in Healthy People to Test How Zongertinib is Taken up in the Body When Given as Tablets Made by Two Different Manufacturers With or Without Food' on Aug. 24.
Brief Summary: The main objective of this trial is to establish the bioequivalence of Zongertinib tablets from two different manufacturers following oral administration.
Study Start Date: Sept. 09
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Zongertinib, Formulation A, reference product
Zongertinib, Formulation A, reference product
DRUG: Zongertinib Formulation B, test product
Zongertinib Formulation B, test product
Recruitment Status: NOT...